CANCER PREVENTION
AND CONTROL

COLLOQUIUM

 

Insulin Like Growth Factor 1 (IGF-1)

and Cancer

 

  

 

Shoshana Yakar, PhD

 

Speaker

Dr. Yakar is a Staff Scientist in the Diabetes Branch of the National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, in Bethesda, Maryland.

Learning Objective

To learn if circulating (serum) IGF-1 can serve as a cancer risk marker

Target Audience

Researchers and clinicians actively involved in topics that relate to cancer prevention and control


Date/Time/Place

Wednesday, November 17, 2004, 11:00 am
Executive Plaza North
Conference Room G
6130 Executive Boulevard
Rockville, Maryland


For Additional Information

Office of Preventive Oncology
301-496-8640

 If you are a person with a disability and require any assistive device, services or other reasonable accommodations to participate in this activity, please contact the Office of Preventive Oncology at 301-496-8640 at least one week in advance of the lecture date to discuss your accommodations needs.

The National Institutes of Health/Foundation for Advanced Education in the Sciences is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
The National Institutes of Health/Foundation for Advanced Education in the Sciences designates this educational activity for a maximum of 41 hours in Category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
COLLOQUIUM
Home Page
DCP
Home Page
NCI
Home Page
OPO
Home Page